Motley Fool Money cover image

Twitter Faces Threats from AI and Meta

Motley Fool Money

00:00

Exploring the Growth Potential of Medical Aesthetics with Evolis

This chapter explores the medical aesthetics industry, highlighting Evolis and its flagship product, Juveau, which rivals Botox. It discusses Evolis's unique market position, growth potential, and plans for expansion into dermal fillers by 2028.

Play episode from 15:26
Transcript

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app